HBC(SH:603077) Xin Lang Cai Jing·2026-01-22 01:57Group 1 - The core viewpoint of the news is that Hebang Biotechnology has seen a significant stock price increase, with a 5.35% rise on January 22, reaching 2.56 yuan per share, and a total market capitalization of 22.609 billion yuan [1] - Hebang Biotechnology has experienced a cumulative increase of 9.46% over the past three days, indicating strong market performance [1] - The company, established on August 1, 2002, specializes in the manufacturing of pesticides, fine chemicals, and various glass products, with chemical products accounting for 85.89% of its main business revenue [1] Group 2 - From the perspective of fund holdings, one fund under Jiao Yin Schroder has a significant position in Hebang Biotechnology, with 1.8739 million shares held, representing 0.39% of the fund's net value [2] - The fund, Jiao Yin Zhi Xuan Xing Guang Mixed (FOF-LOF) A, has generated a floating profit of approximately 243,600 yuan today and 393,500 yuan during the three-day price increase [2] - The fund manager, Liu Bing, has a tenure of 4 years and 153 days, with the fund's total asset size at 1.637 billion yuan and a best return of 53.13% during his management period [2]